СЕПСИС В ИНТЕНСИВНОЙ ТЕРАПИИ: СОВРЕМЕННЫЕ АСПЕКТЫ ДИАГНОСТИКИ




Р. Э. Якубцевич (Yakubtsevich R. E.)

Аннотация


Целью проведенного обзора литературы было обобщить результаты современных взглядов на вопросы диагностики сепсиса. Проанализированы   53 русскоязычных и англоязычных источника. Внимание уделено новым маркерам ранней диагностики сепсиса, а также тяжелого сепсиса и его осложнений. Указано на целесообразность клинического определения прокальцитонина и пресепсина  как наиболее изученных маркеров сепсиса.


Ключевые слова


сепсис; синдром полиорганной дисфункции; острый респираторный дистресс-синдром; прокальцитонин; пресепсин; индол; интерлейкин

Полный текст:

Литература


Методы экстракорпоральной гемокоррекции и их влияние на продукты микробного метаболизма у пациентов с сепсисом / Р. Э. Якубцевич [и др.] // Анестезиология и реаниматология, N 5.- 2015, C. 67-70.

A multicenter, prospective evaluation of quality of care and mortality in Japan based on the Surviving Sepsis Campaign guidelines / S. Fujishima [et al] // J. Infect. Chemother.- 2014.- Vol. 20, N 2.- P. 115-120.

A validation of presepsin levels in kidney dysfunction patients: four case reports / A. Kotera [et al] // J. Intens. Care - 2014.- Vol. 2, N 1.- P. 63.

Association between serum substance P levels and mortality in patients with severe sepsis / L. Lorente [et al] // J. Crit. Care.- 2015.- Vol. 23.- P.12-15.

Beutler, B. A. TLRs and innate immunity / B. F. Beutler // Blood.- 2009.- Vol. 113.- P. 1399–1407.

Clinical impact of kidney function on presepsin levels / T. Nagata [et al] // PLoS One.- 2015.- Vol. 10.- N 6.- P.92.

Clinical relevance of procalcitonin and C-reactive protein as infection markers in renal impairment: a cross-sectional study / J. H. Park [et al] // Crit. Care - 2014.- Vol. 18, N 6.- P. 640.

Clinical year in review 2014: critical care medicine / J. M. Lee [et al] // Tuberc. Respir. Dis.- 2014.- Vol. 77. P- 6-12.

Comparison of Charlson's weighted index of comorbidities with the chronic health score for the prediction of mortality in septic patients / Y. Cui [et al] // Chin. Med. J. Engl.- 2014. - Vol. 127, N 14.- P. 2623-2627.

Comparison of human B cell activation by TLR7 and TLR9 agonists / J. A. Hanten [et al] // BMC Immunol.- 2008.- Vol. 9.- P. 39.

Comparison of simplified acute physiology score III and other scoring systems in prediction of 28-day prognosis in patients with severe sepsis / Y. Li Y. [et al] // Zhonghua Wei Zhong Bing Ji Jiu Yi Xue.- 2015.- Vol. 27, N 6.- P. 454-459.

Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran / H. M. Kim [et al] // Cell.- 2007.- Vol. 130.- P. 906–917.

Depressed monocytic activity may be a predictor for sepsis / N. Bhardwaj [et al] // J. Lab. Physicians.- 2015.- Vol. 7, N 1.- P. 26-31.

Diagnosis and evaluation of severity of sepsis via the use of biomarkers and profiles of 13 cytokines: a multiplex analysis / D. W. Jekarl [et al] // Clin. Chem. Lab. Med.- 2015.- Vol. 53, N 4.- P. 575-581.

Diagnostic and prognostic role of procalcitonin (PCT) and MR-pro-Adrenomedullin (MR-proADM) in bacterial infections / S. Angeletti [et al] // APMIS.- 2015.- Vol. 6.- P. 8.

Diagnostic and prognostic utility of tissue factor for severe sepsis and sepsis-induced acute lung injury / M. Xue [et al] // J. Transl. Med.- 2015.- Vol. 30, N 13.- P. 172.

Diagnostic and prognostic value of presepsin in emergency patients with early sepsis using the new assay PATHFAST Presepsin / E. Spanuth [et al] // Euro Med. Lab.- 2011.- N 5.- P.112-116.

Diagnostic and prognostic value of presepsin in the emergency department / T. O. Popa [et al] // Rev. Med. Chir. Soc. Med. Nat. Iasi.- 2015.- Vol. 119, N 1.- P. 69-76.

Diagnostic and prognostic values of serum procalcitonin and C-reactive protein in patients of bacterial sepsis / X. Huang [et al] // Zhonghua Yi Xue Za Zhi.- 2014.- Vol. 94, N 27.- P. 2106-2109.

Diagnostic value and prognostic evaluation of Presepsin for sepsis in an emergency department / B. Liu [et al] // Crit. Care- 2013.- Vol. 17, N 5.- P. 244.

Discovery and development of Toll-like receptor 4 (TLR4) antagonists: a new paradigm for treating sepsis and other disease / C.G. Leon [et al] // Pharm. Res.- 2008.- Vol. 25, N 8.- P. 1751-1761.

Guideline bundles adherence and mortality in severe sepsis and septic shock / A. R. Van Zanten [et al] // Crit. Care Med.- 2014.- Vol. 42, N 8.- P. 1890-1898.

Increased NGAL is associated with mortality and multiple organ dysfunction syndrome in severe sepsis and septic shock / B. Wang [et al] // Shock.- 2015.- Vol. 22.- P. 17.

Increased plasma vaspin concentration in patients with sepsis: an exploratory examination / M. C. Motal [et al] // Biochem. Med (Zagreb).- 2015.- Vol. 25, N 1.- P. 90-96.

In-hospital vs. 30-day mortality in the critically ill - a 2-year Swedish intensive care cohort analysis / K. Rydenfelt [et al] // Acta Anaesthesiol. Scand.- 2015.- N 4.- P. 10.

Interleukin-6 as an early diagnostic marker for bacterial sepsis in patients with liver cirrhosis / S. Lin [et al] // J. Crit Care.- 2015.- Vol. 30, N 4.- P. 732-738.

Interleukin-8 for diagnosis of neonatal sepsis: a metaanalysis / M. Zhou [et al] // PLoS One.- 2015.- Vol. 21, N 10.- P. 5.

Investigation of the procalcitonin and microbiology test and antibiotics situation from our hospital / K. Fujii [et al] // Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi.- 2014.- Vol. 25, N 1.- P.7-15.

Is C-reactive protein a good prognostic marker in septic patients? / J. Silvestre [et al] // Intensive Care Med.- 2009.- Vol. 24.- P. 1158-1168.

Limulus amebocyte lysate testing: adapting it for determination of bacterial endotoxin in 99mTc-labeled radiopharmaceuticals at a hospital radiopharmacy / A. Mitra [et al] // J. Nucl. Med. Technol.- 2014.- Vol. 42, N 4.- P. 278-282.

Microbiological characteristics of sepsis in a University hospital / A.V. Vendemiato [et al] // BMC Infect. Dis.-2015.- Vol. 14, N 15.- P. 58.

Mortality in Emergency Department Sepsis (MEDS) score: A prospectively derived and validated clinical prediction rule / N. I. Shapiro [et al] // Crit. Care Med.- 2003.- Vol. 31, N3.- P. 670-675.

Neutrophil CD64 expression as a diagnostic marker for sepsis in adult patients: a meta-analysis / X. Wang [et al] // Crit. Care.- 2015.- Vol. 19, N 1.- P. 245.

Persistent inflammation and immunosuppression: A common syndrome and new horizon for surgical intensive care / L. F. Gentile [et al] // J. Trauma Acute Care Surg.- 2012.- Vol. 72, N 6.- P. 1491–1501.

Plasma neutrophil-gelatinase-associated lipocalin and cystatin C could early diagnosecontrast-induced acute kidney injury in patients with renal insufficiency undergoing an elective percutaneous coronary intervention / X. L. Liu [et al] // Chin. Med. J. Engl.– 2012.– Vol. 125, N 6.– P. 1051–1056.

Procalcitonin for the differential diagnosis of infectious and non-infectious systemic inflammatory response syndrome after cardiac operation / Z. Dong [et al] // Zhonghua Wei Zhong Bing Ji Jiu Yi Xue.- 2014.- Vol. 26, N 7.- P. 478-479.

Procalcitonin is a marker of gram-negative bacteremia in patients with sepsis / S.Y. Guo [et al] // Am. J. Med. Sci.- 2015.- Vol. 349, N 6.- P. 499-504.

Procalcitonin versus C-reactive protein: usefulness as biomarker of sepsis in ICU patient / W. Nargis [et al] // Int. J. Crit. Illn. Inj. Sci.- 2014.- Vol. 4, N 3.- P. 195-199.

Results of the severe sepsis registry in intensive care units in Poland from 2003-2009 / A. Kubler [et al] // Anaesthesiol. Intensive Ther.- 2015.- Vol. 47, N 1.- P. 7-13.

Serum Concentrations of Interleukin-6, Procalcitonin, and C-Reactive Protein: Discrimination of Septical Complications and Systemic Inflammatory Response Syndrome after Pediatric Surgery / F. Neunhoeffer [et al] // Eur J. Pediatr. Surg.- 2015.- Vol. 2, P.- 134-138.

Serum interleukin 17 as an early prognostic biomarker of severe acute pancreatitis receiving continuous blood purification / S.R. Dai [et al] // Int. J. Artif. Organs.- 2015.- Vol. 38, N 4.- P.192-198.

Serum levels of soluble CD14 subtype reflect the APACHE II and SOFA Scor / M. Kojika [et al] // Medical Postgraduates.- 2010.- Vol. 48, N 1.- P. 46-50.

Severe sepsis in older adults / R. Umberger [et al] // Crit. Care Nurs Q.- 2015.- Vol. 38, N 3.- P. 259-270.

Sganga, G. Surgical sepsis / G. Sganga // Urologia.- 2015.- N3.- P. 9.

Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock. / R. P. Dellinger [et al] //Crit. Care Med.- 2013.- Vol. 41, N 2. – P. 580-637.

Systemic inflammatory response syndrome (SIRS): molecular pathophysiology and gene therapy / N. Matsuda [et al] // J. Pharmacol. Sci.- 2006.- Vol. 101.- P. 189-198.

The clinical significance of circulating soluble RAGE in patients with severe sepsis / H. Matsumoto [et al] // Trauma Acute Care Surg.- 2015.- Vol. 21.- P. 123-127.

The DISPARITY Study: do gender differences exist in Surviving Sepsis Campaign resuscitation bundle completion, completion of individual bundle elements, or sepsis mortality? / T. E. Madsen [et al] // J. Crit. Care- 2014.- Vol. 29, N 3.- P. 473.

The Limulus Amebocyte Lysate assay may be unsuitable for detecting endotoxin in blood of healthy female subjects / A. Gnauck [et al] // J. Immunol. Methods.- 2015.- Vol. 416.- P. 146-156.

50. The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex / B. S. Park [et al] // Nature.- 2009.- Vol. 458.- P. 1191–1195.

Usefulness of presepsin (sCD14-ST) measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndrome / T. Shozushima [et al] // J. Infect. Chemother.- 2011.- Vol. 17, N 6.- P. 764-769.

Value of interleukin-27 as a diagnostic biomarker of sepsis in critically ill adults / J. Fu [et al] // Zhonghua Wei Zhong Bing Ji Jiu Yi Xue.- 2015.- Vol. 27, N 6.- P. 460-464.

Variations in organism-specific severe sepsis mortality in the United States: 1999-2008 / C. Ani [et al] // Crit. Care Med.- 2015.- Vol. 43, N 1.- P. 65-77.


Ссылки

  • На текущий момент ссылки отсутствуют.